Were you planning on attending the upcoming BEBPA in Seattle? So were we, but due to the COVID-19 outbreak, we’re glad to hear that the US BEBPA Bioassay Conference is switching to a virtual format.

 

Connect with our scientific leaders and business development team at Booth B21. Learn more on how we accelerate your bioanalytical service needs for your drug development projects!

 

Stop by Booth 61 at the FOB - European Antibody Congress

Join us in Basel for the exciting opportunity to find out how we can help streamline your future projects. The Svar sales representatives; Libby Naylor and Maria Ekerot, are available to discuss how the products Svar is developing and the services Wieslab Bioanalytical Services offer can help address the obstacles and analytical challenges involved in developing Biologics.  

Stop by Booth 61 and join us over a Swedish Fika and – take our pop quiz for a chance to win a Swedish designer backpack!

If you'd like to know more about how our iLite® cell-based assay technology and Bioanalytical Services can help accelerate your drug development? Make sure you book a meeting in advance and don't miss our poster on "How to Select and Optimize Characterization Criteria for Assay Ready Cells – A Case Study". Stop by the poster zone during the drinks reception October 16th to get a personal walk thru with our representative Libby Naylor and Maria Ekerot. 

Book a meeting

Abstract:

"Characterization of cultured cell lines for production of biologic material and cell lines used for potency applications are outlined in various guidance documents – but there is an absence of specific instructive information about the requirements for genetically modified cell lines, such as modified cell banks used for production of assay ready cells utilized for e.g. in bioassays, ADCC assays and neutralization assays in GxP applications.

Here we offer examples from 10+ years working in development, validation and production of custom genetically modified cell lines and assay ready cells used in reporter gen assays. Examples will showcase critical aspects of characterization and include lessons learned as well as recommendations on what can be considered as an appropriate level for assay read cells."


#FOB2019 #svarlifescience #wieslab #bioanalyticalservices #laboratoryservices #cellbasedassays #ilite #bioanalytical #drugdevelopment #genetherapy #development #innovation #complement 

Exhibitions Linkedin HT2019-10

15 October - 17 October 2019

This week we're attending the European Bioassays Conference in Prague

Join us there and let's explore Best Practices for the Best Potency Assays together!

We are very excited to announce that we will be hosting hosting a scientific talk at 09.45 on September 26th during the “Session 2: Hot Topics: Ready-to-Use Cells". The title of the talk is “How to Select and Optimize Characterization Criteria for Assay Ready Cells – A Case Study” presented by Karin Blume, scientist from the Svar Research and Development Team.

Abstract:
Characterization of cultured cell lines for production of biologic material and cell lines used for potency applications are outlined in various guidance documents – but there is an absence of specific instructive information about the requirements for genetically modified cell lines, such as modified cell banks used for production of assay ready cells utilized for e.g. in bioassays, ADCC assays and neutralization assays in GxP applications.

Here we offer examples from 10+ years working in development, validation and production of custom genetically modified cell lines and assay ready cells used in reporter gene assays. Examples will showcase critical aspects of characterization and include lessons learned as well as recommendations on what can be considered as an appropriate level for assay read cells.


Make sure to stop by the Svar Booth while in Prague to meet up with Therese Segerstein - Product Manager iLite, Camilla Duborn - Senior Director Sales & Global Marketing, Karin Blume - Scientist R&D and Libby Naylor - Regional Sales Manager UK.

Learn more about our exiting products and services that can help streamline your drug development and gene therapy projects!

 

Exhibitions Linkedin HT2019-4

25 September - 27 September 2019